Canvax participates in Cenit Oncológica project

Date: 2013-09-13 by Canvax
Canvax participates in Cenit Oncológica project

The Oncology Consortium, composed of seven Spanish biotech companies and led by PharmaMar, has generated since its launch four years ago, a total of 9 patent applications, 5 papers and 13 posters at international conferences, plus three doctoral theses and 12 scientific publications

Together with Canvax and PharmaMar, the other companies involved in the consortium are Faes Farma, Genómica, GP-Pharm, Tigenix and Geadic Biotec. The project aims to establish a new paradigm in the use of biomarkers in oncology, which serve as a starting point for the development and application of new therapies in personalized cancer treatments.

For more details, read the full article here.